4th Cir. Upholds Dismissal of Lawsuit Targeting Purolite’s Cholesterol Drug



DOCUMENTS
  • Order
  • Order


BALTIMORE — The 4th Circuit U.S. Court of Appeals has upheld dismissal of a lawsuit alleging gastrointestinal injuries caused by a cholesterol drug, ruling that its manufacturer, Purolite Corp., adequately warned the prescribing doctor of the drug’s risks.

In a Jan. 3 order, the appellate court noted the plaintiff herself pled that her doctor was aware of cholestyramine’s side effects, but told her to take the drug anyway.

Mariana Savu took cholestyramine for five months in 2019 to treat mycotoxin-induced illness following exposure to toxic mold and began to experience severe stomach pain, vomiting, dizziness, rapid breathing, and confusion. She …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS